Barclays PLC Sarepta Therapeutics, Inc. Put Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 15, 2024	BUY	$124.33 - $156.75 $621,650 - $783,750	5,000 New	5,000 $624,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $468,500 - $707,650	5,000 New	5,000 $647,000
Q3 2021 Nov 09, 2021	SELL	$65.97 - $92.48 $145,134 - $203,456	-2,200 Reduced 27.5%	5,800 $536,000
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $3.05 Million - $4.14 Million	-24,000 Reduced 75.0%	8,000 $1.12 Million
Q2 2020 Aug 12, 2020	SELL	$93.0 - $171.7 $9.9 Million - $18.3 Million	-106,500 Reduced 76.9%	32,000 $5.13 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $280,092 - $447,575	-3,400 Reduced 2.4%	138,500 $13.5 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $3.61 Million - $6.4 Million	47,200 Added 49.84%	141,900 $18.3 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $5.18 Million - $11.2 Million	-71,200 Reduced 42.92%	94,700 $7.13 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $493,724 - $668,580	-4,400 Reduced 2.58%	165,900 $25.2 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $12.4 Million - $17.6 Million	116,000 Added 213.63%	170,300 $20.3 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $1.94 Million - $2.96 Million	19,900 Added 57.85%	54,300 $5.93 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $6.72 Million - $9.42 Million	-58,300 Reduced 62.89%	34,400 $5.56 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $4.31 Million - $9.24 Million	60,100 Added 184.36%	92,700 $12.3 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $9.98 Million - $15.2 Million	-184,700 Reduced 85.0%	32,600 $2.42 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $5.65 Million - $6.73 Million	118,600 Added 120.16%	217,300 $12.1 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $3.53 Million - $4.65 Million	98,700	98,700 $4.48 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.26 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.09 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$763 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$531 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$521 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account